[1]
Sara Tariq Husseen Al-Bayate et al. 2023. Prolidase Specificity as a diagnostic marker for breast cancer. Journal of Population Therapeutics and Clinical Pharmacology. 30, 2 (Mar. 2023), 393–400. DOI:https://doi.org/10.47750/jptcp.2023.1122.